Literature DB >> 30797666

Progress in biological reconstruction and enhanced bone revitalization for bone defects.

Norio Yamamoto1, Katsuhiro Hayashi1, Hiroyuki Tsuchiya2.   

Abstract

Bone defect reconstruction with artificial materials may produce good functional recovery in the short term. Over time, the durability of artificial materials becomes an issue, and therefore, artificial materials cannot be considered a permanent solution to reconstruction. For long-term outcomes, the goal is to regain function, permanence, and form that are as close to normal as possible. Thus, physiological materials are desirable for use in reconstruction. Biological reconstruction involves the use of materials that are modified in vivo following reconstruction of bone defects. The goal is to achieve bone union, bone revival and remodeling, with biointegration of soft tissue and bone. Allograft use has been the mainstay of bone defect reconstruction in most parts of the world, although in some countries like Japan, allogeneic bone is difficult to obtain due to socio-religious concerns. Therefore, we developed new biological reconstruction techniques to overcome this problem. Bone derived from distraction osteogenesis is autologous bone, which must be an ideal reconstruction material for its biological affinity, strength, resilience, and immunity to infection. When applying this method to patients with malignant disease however, it is important to preserve as much of the local soft tissue as possible, and the clinician must be especially careful of infection and callus formation. Liquid nitrogen treatment of tumor-bearing bone produces equal, if not better, bone revitalization compared to other forms of treatment to date. Reconstruction with liquid nitrogen-treated bone involves resecting the diseased bone and returning it to the body following liquid nitrogen treatment (free-freezing method). Another method involves dislocating the joint proximal to the tumor, or cutting the bone while the distal side remains attached to the body and the limb inverted and treated with liquid nitrogen (pedicle freezing method). When both methods are possible, the pedicle freezing method is preferable since it is performed with minimal osteotomy. Our recent research has looked into the possible role of adipose-derived stem cells in promoting bone fusion and revitalization. This method has produced promising results for the future of biological reconstruction.
Copyright © 2019 The Japanese Orthopaedic Association. Published by Elsevier B.V. All rights reserved.

Entities:  

Year:  2019        PMID: 30797666     DOI: 10.1016/j.jos.2019.01.015

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  4 in total

1.  Risk factors and outcomes for failure of biological reconstruction after resection of primary malignant bone tumors in the extremities.

Authors:  Taweechok Wisanuyotin; Permsak Paholpak; Winai Sirichativapee; Weerachai Kosuwon
Journal:  Sci Rep       Date:  2021-10-14       Impact factor: 4.379

2.  Analyzing BMP2, FGFR, and TGF Beta Expressions in High-Grade Osteosarcoma Untreated and Treated Autografts Using Proteomic Analysis.

Authors:  Rashmi Madda; Chao-Ming Chen; Cheng-Fong Chen; Jir-You Wang; Hsin-Yi Wu; Po-Kuei Wu; Wei-Ming Chen
Journal:  Int J Mol Sci       Date:  2022-07-03       Impact factor: 6.208

3.  Allograft versus autograft for reconstruction after resection of primary bone tumors: a comparative study of long-term clinical outcomes and risk factors for failure of reconstruction.

Authors:  Taweechok Wisanuyotin; Permsak Paholpak; Winai Sirichativapee; Weerachai Kosuwon
Journal:  Sci Rep       Date:  2022-08-23       Impact factor: 4.996

Review 4.  Strategies for large bone defect reconstruction after trauma, infections or tumour excision: a comprehensive review of the literature.

Authors:  Filippo Migliorini; Gerardo La Padula; Ernesto Torsiello; Filippo Spiezia; Francesco Oliva; Nicola Maffulli
Journal:  Eur J Med Res       Date:  2021-10-02       Impact factor: 2.175

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.